AnandRathi

Concord Drugs Ltd Fundamental Analysis

Last Updated Date: 27 Aug 2026
79.71
-0.79 (-0.98%)

Concord Drugs Ltd (Concord Drugs) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹106 crore.

Concord Drugs Ltd Overview

Market cap₹106 Crs
Volume3,894
Prev. Close₹80.50
Year range₹56.00 - ₹92.52
Total Value₹3,10,390.74
ISININE858L01010

Concord Drugs Ltd Fundamental Analysis

ROCE(TTM)4.82%
P/E Ratio (TTM)51.94
P/B Ratio2.19
Debt to Equity0.24
ROE2.14%
EPS (TTM)1.55
Dividend Yield0.00%
Book Value36.82
Profit Margin2.45%
Operating Margin5.05%

Concord Drugs Ltd Historical Performance

1 Month Return18.50%
6 Month Return3.13%
3 Year Return123.92%
3 Month Return-1.57%
1 Year Return42.96%
5 Year Return193.26%

Concord Drugs Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research